NCT05048524 2024-03-27
Peri-operative SLOG for Localized Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown
Clinical Trials
22 trialsNCT04617457 2024-01-12
HOLIPANC
University of Cologne
Phase 2 Unknown
NCT04324307 2023-09-01
Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
Changhai Hospital
Phase 1/2 Unknown
NCT03487016 2022-09-08
FOOTPATH
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT01591733 2021-05-28
FOLFIRINOX + RT for Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT02896803 2020-11-10
PanFLOX
Instituto do Cancer do Estado de São Paulo
Phase 2 Unknown
NCT01821729 2020-09-25
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT02635971 2020-03-05
Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer
Fudan University
Phase 2 Unknown
NCT03825328 2019-01-31
A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )
Harbin Medical University
Phase 2 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT03607643 2018-07-31
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
Phase 1/2 Unknown
NCT03167112 2017-08-29
Folfirinox
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Unknown
NCT01771146 2017-01-31
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Baylor Research Institute
Phase NA Unknown
NCT02506842 2016-08-11
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Fudan University
Phase 3 Unknown
NCT01586611 2014-10-02
Panc001
AHS Cancer Control Alberta
Phase 3 Unknown
NCT00274885 2011-12-05
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
National Cancer Institute (NCI)
Phase 4 Unknown
NCT00690300 2010-03-03
Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer
University of Ulm
Phase 2 Unknown
NCT00006117 2009-10-30
Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00275119 2009-02-09
Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00075452 2008-07-24
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00268411 2008-05-27
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00323583 2007-05-08
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
Seattle Cancer Treatment and Wellness Center
Phase 2 Unknown